Keyphrases
Polypeptide
100%
Biological Activity
100%
Glucose-dependent Insulinotropic Polypeptide
100%
Ser2
100%
Dipeptidyl peptidase-IV (DPP-IV)
14%
Glucagon-like
14%
Glycine
14%
Incubation
7%
IC50 Value
7%
Beneficial Effects
7%
Diabetic
7%
Glycemic Control
7%
Degradation in Vitro
7%
Glucose Effect
7%
Diabetes
7%
Chinese Hamster Lung Fibroblast
7%
Plasma Instabilities
7%
Antidiabetic Potential
7%
Insulin Response
7%
BRIN-BD11 Cells
7%
Glucose-dependent Insulinotropic Polypeptide Receptor
7%
Insulinotropic Activity
7%
Enzymatic Degradation
7%
Hydrolysis Rate
7%
Type 2 Diabetes Prevention
7%
Potential Therapeutics
7%
Glycemic Excursion
7%
Duration of Action
7%
Therapeutic Potential
7%
Glucose-lowering Drugs
7%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Biological Activity
100%
Polypeptide
100%
Serine
14%
Glucagon-Like Peptide-1
14%
EC50
7%
Ob/Ob Mouse
7%
Diabetic Obesity
7%
Chinese Hamster
7%
Non Insulin Dependent Diabetes Mellitus
7%
Gastric Inhibitory Polypeptide Receptor
7%
Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
100%
Biological Activity
100%
Blood Plasma
21%
Glucagon-Like Peptide-1
14%
Serine
14%
Cyclic Adenosine Monophosphate
7%
N-Terminus
7%
EC50
7%
Enzymatic Hydrolysis
7%
Fibroblast
7%
Ob/Ob Mouse
7%
Gastric Inhibitory Polypeptide Receptor
7%
Chinese Hamster
7%
Insulin Response
7%
Glycemic Control
7%
Enzymatic Degradation
7%